ImmuCell Corporation (ICCC)

ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61	46	39	47	62	43
Market Cap Growth	4.74%	16.33%	-16.51%	-23.70%	44.31%	15.59%
Enterprise Value	69	58	54	51	62	48
Last Close Price	6.53	5.15	5.09	6.10	8.00	5.95
PS Ratio	2.03	1.73	2.26	2.55	3.22	2.80
PB Ratio	2.02	1.67	1.58	1.56	1.90	1.52
P/TBV Ratio	2.06	1.68	1.59	1.56	1.91	1.53
P/FCF Ratio	75.27	-	-	-	-	-
P/OCF Ratio	39.24	128.23	-	-	64.91	32.62
EV/Sales Ratio	2.54	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	24.11	39.63	-	65.78	22.78	49.62
EV/EBIT Ratio	376.31	-	-	-	240.62	-
EV/FCF Ratio	88.03	-	-	-	-	-
Debt / Equity Ratio	0.51	0.55	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	4.34	7.75	-	12.96	3.57	9.69
Debt / FCF Ratio	18.58	-	-	-	-	-
Asset Turnover	0.62	0.60	0.39	0.42	0.45	0.39
Inventory Turnover	2.47	2.43	1.89	2.26	4.09	3.68
Quick Ratio	2.07	1.72	0.76	2.47	5.09	4.44
Current Ratio	4.12	3.41	2.73	4.56	6.42	5.50
Return on Equity (ROE)	-1.01%	-8.21%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	0.26%	-1.73%	-7.36%	-2.39%	0.38%	-2.18%
Return on Capital (ROIC)	0.27%	-1.83%	-7.72%	-2.49%	0.39%	-2.26%
Return on Capital Employed (ROCE)	0.40%	-	-	-	0.60%	-
Earnings Yield	-0.46%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	1.33%	-0.24%	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-9.37%	-5.42%	-0.03%	-2.01%	-5.25%	-5.78%

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q